VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VNDA

<< 前へ 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/06/18	06 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/06/18	06 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/06/18	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/06/14	05 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/06/11	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/05/31	22 : 45	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at the Jefferies 2019 Global Healthcare Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/05/23	05 : 01	PR Newswire (US)	Tradipitant in the Treatment of Gastroparesis: Vanda Presents Clinical Trial Results at DDW 2019	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/05/22	06 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/05/10	05 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/05/03	20 : 03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/05/02	05 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/05/02	05 : 01	PR Newswire (US)	Vanda Pharmaceuticals Reports First Quarter 2019 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/30	21 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/26	05 : 38	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/26	05 : 34	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/25	06 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/25	06 : 33	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/25	05 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/25	05 : 30	PR Newswire (US)	Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/19	05 : 30	PR Newswire (US)	Vanda Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/04/07	02 : 10	Business Wire	INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Vanda Pharmaceutical...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/08	06 : 01	PR Newswire (US)	Vanda Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/07	21 : 57	PR Newswire (US)	(VNDA) Alert: Johnson Fistel Reminds Investors of Deadline in the Class Action Lawsuit Against Vanda Pharmaceuticals Inc.	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/05	22 : 20	GlobeNewswire Inc.	Analysis: Positioning to Benefit within IHS Markit, PRA Group, Acacia Communications, Vanda Pharmaceuticals, Gran Tierra Ener...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/05	07 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/05	07 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/05	07 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/05	07 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/05	00 : 59	Business Wire	IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/03/02	21 : 00	Business Wire	INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals I...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc